Safety Alerts & Recalls

What does this mean?

This recall from Nycomed was issued at a warehouse/pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you use any of these recalled products and are concerned, you should consult with your physician or pharmacist.

Nycomed Recalls Several Different Eye Ointments

Nycomed US, Inc, is recalling several different eye ointments that are commonly used in the treatment of conjunctivitis and other infections of the eye. The following ointments and lot numbers are being recalled because these lots may be contaminated with bacteria: 1) Erythromycin Ophthalmic Ointment, 0.5% (5 mg/g) in 1 gram tubes - Lots R46, R50, R64, R66, R77, R78, R79, R80, R82, 50A, 52A, 53A, and 56A

2) Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, 500 bacitracin units + 10,000 polymyxin B units per gram, in 3.5 g tubes - Lot 67A

3) Gentamicin Sulfate Ophthalmic Ointment, 3 mg/gram, in 3.5 g tubes - Lot 13A

4) Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, 3.5mg Neomycin + 10,000 Polymyxin B units + 1mg Dexamethasone per gram, in 3.5 g tubes - Lot 29A

5) Puralube Ointment (Petrolatum Ophthalmic Ointment), in 1 g tubes - Lots R09, R56, R90, and 68A

This recall alert only applies to these specific eye ointments and lot numbers made by Nycomed. No other lots, strengths, brands, or formulations were involved in this recall.

To view the FDA notice about this recall, please visit: more information here

Source: FDA
Publication Date: 2010-05-12
Last Updated: 2010-05-12
Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.